An Important Step Forward for Biosimilars in Cancer Treatment. Academic Article uri icon

Overview

publication date

  • July 1, 2017

Research

keywords

  • Biosimilar Pharmaceuticals
  • Breast Neoplasms
  • Receptor, ErbB-2
  • Taxoids
  • Trastuzumab

Identity

Scopus Document Identifier

  • 85037348445

Digital Object Identifier (DOI)

  • 10.1001/jamaoncol.2016.6789

PubMed ID

  • 28196209

Additional Document Info

volume

  • 3

issue

  • 7